Ocata Therapeutics, Inc.
SEC CIK 1140098 · OTCBB:ACTC · last insider filing 2016-02-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Shapiro Alan C | Director | filed 2006 - 2016 |
| Perry Gregory D | Director | filed 2012 - 2016 |
| Langer Robert | Director | filed 2012 - 2016 |
| Levy Brian | Director | filed 2015 - 2016 |
| Loshitzer Zohar | Director | filed 2012 - 2016 |
| Wotton Paul K | Director · President and CEO | filed 2014 - 2016 |
| Heffernan Michael Thomas | Director | filed 2012 - 2016 |
| Rabin Gary H | Director · CHAIRMAN & CFO | filed 2010 - 2013 |
| Ruoslahti Erkki | Director | filed 2006 - 2011 |
| Caldwell William M | Director · Chief Executive Officer | filed 2007 - 2010 |
| West Michael D | Director | filed 2007 - 2007 |
| Walton Alan G | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Jooste H Le Roux | SVP of Bus Development & CCO | filed 2014 - 2016 |
| Lanza Robert | VP - Med & Sci Development | filed 2006 - 2016 |
| Myles Edward H | COO and CFO | filed 2013 - 2016 |
| Anglade Eddy | EVP of Clinical Development | filed 2014 - 2016 |
| Wolkind Ivan | SVP, Chief Accounting Officer | filed 2006 - 2008 |
| Dinsmore Jonathan | SVP, Regulatory & Clinical | filed 2008 - 2008 |
| Atzen Jonathan F | SVP and General Counsel | filed 2006 - 2007 |
| Huertas Pedro | Chief Development Officer | filed 2007 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.